News
Explore why Strut Health is redefining affordable, personalized online care for weight loss, sexual wellness, skin health, ...
Phase 3 trial results released by Protagonist Therapeutics has revealed that icotrokinra, an oral IL-23 receptor inhibitor, achieved clear or nearly clear skin in 66% of patients with ...
The story of chronic itch and its impact on quality of life is one dermatologists have heard often. Until recently, treatment ...
A study explores key aspects of gargalesis, such as why certain areas of the body are more sensitive, why children tend to be ...
Among the more unconventional options for treating long COVID, nicotine – delivered via low-dose transdermal patches – has ...
SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today ...
Women diagnosed with DCIS face a threefold higher risk of breast cancer mortality. Learn the warning signs, treatment options ...
Explore the best THC gummies for pain relief at top weed sellers in our detailed review & discover top options to potentially ...
Announced Global Collaboration with Novo Nordisk to Develop Oral Small Molecules for Metabolic Diseases with Over $2.2 Billion in Potential Milestone Payments On Track to Select a Next-Generation Oral ...
AstraZeneca to showcase latest research on comprehensive portfolio and pipeline aimed at transforming respiratory diseases at ATS 2025: Cambridge, UK Wednesday, May 14, 2025, 13:0 ...
The early months of 2025 have seen a surge of research centered on cannabidiol (CBD), with studies investigating its role in ...
A research team has identified a molecular mechanism that coordinates the operation of the N-methyl-D-aspartate (NMDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results